Related Experiment Videos
Two drugs facing key patent expirations and potential generic entry from November 2020 to December 2020
1DrugPatentWatch, Washington DC, USA.
Pharmaceutical Patent Analyst
|December 22, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Six drugs facing key patent expirations and potential generic entry from May to June 2022.
Pharmaceutical patent analyst·2022
Two drugs facing key patent expirations and potential generic entry from July to August 2020.
Pharmaceutical patent analyst·2020
Five drugs facing key patent expirations and potential generic entry from April to May 2020.
Pharmaceutical patent analyst·2020
Where Are Drugs Invented, and Why Does It Matter?
ACS medicinal chemistry letters·2017
Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight.
Pharmaceutical patent analyst·2025
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.
Pharmaceutical patent analyst·2025
Trivalent bispecific anti-MSLN2/CD3 antibody for cancer treatment.
Pharmaceutical patent analyst·2025
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma.
Pharmaceutical patent analyst·2025
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.
Pharmaceutical patent analyst·2025
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024.
Pharmaceutical patent analyst·2025
Common Deficiencies in Dossiers of Finished Pharmaceutical Products Submitted for Registration and Related Factors: A Mixed-Method Study in Tanzania.
Therapeutic innovation & regulatory science·2026
Prescribing for the patient and the planet: a pragmatic feasibility study of a behaviour change intervention to reduce liquid amoxicillin prescribing in primary care.
Exploratory research in clinical and social pharmacy·2026
Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug-Polymer Interactions to in vivo Performance.
Drug design, development and therapy·2026
Approval lag and loss for biologic-device combination products in Japan and the United States.
Frontiers in medical technology·2026
An efficient functional screening method for anti ATP hydrolase antibody based on fluorescent probes.
Frontiers in immunology·2026